Reata Pharmaceuticals Inc. Cl A | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
87,758.00
42,008.00
84,732.00
129,780.00
337,790
Total Accounts Receivable
15,243.00
31,926.00
-
-
-
Other Current Assets
3,700.00
3,325.00
2,551.00
3,329.00
4,483
Total Current Assets
106,701.00
77,259.00
87,283.00
133,109.00
342,273
Net Property, Plant & Equipment
2,516.00
1,142.00
819.00
718.00
1,445
Long-Term Note Receivable
307.00
81.00
15.00
2.00
-
Other Assets
872.00
553.00
991.00
1,510.00
1,490
Total Assets
125,911.00
79,035.00
89,108.00
135,339.00
345,208
ST Debt & Current Portion LT Debt
-
-
-
1,229.00
Accounts Payable
765.00
3,531.00
3,830.00
2,067.00
Income Tax Payable
1,220.00
-
-
-
Other Current Liabilities
56,113.00
57,289.00
55,801.00
44,321.00
Total Current Liabilities
58,098.00
60,820.00
59,631.00
47,617.00
Long-Term Debt
-
-
-
18,385.00
Deferred Taxes
15,515.00
-
-
-
Other Liabilities
341,752.00
291,290.00
244,510.00
216,308.00
Total Liabilities
399,850.00
352,110.00
304,141.00
282,310.00
Common Equity (Total)
273,939.00
273,075.00
215,033.00
146,971.00
Total Shareholders' Equity
273,939.00
273,075.00
215,033.00
146,971.00
Total Equity
273,939.00
273,075.00
215,033.00
146,971.00
Liabilities & Shareholders' Equity
125,911.00
79,035.00
89,108.00
135,339.00
About Reata Pharmaceuticals
View Profile
